(Press-News.org) CHICAGO - Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR Annual Meeting 2012.
All of the aberrantly activated translational proteins are regulated by the PI3K/mTOR molecular signaling pathway, which has been implicated in development and progression of several cancers.
More recently, mTOR activation has been tied to resistance to standard endocrine therapy in estrogen-receptor positive breast cancer, said Funda Meric-Bernstam, M.D., professor in MD Anderson's Department of Surgical Oncology, who presented the research at AACR.
"These data underline the importance of the PI3K/mTOR pathway in hormone receptor-positive breast cancer and suggest potential new prognostic factors and therapeutic targets," said Meric-Bernstam, who also is medical director of MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
Two drugs that inhibit mTOR, everolimus and temsirolimus, are approved for treatment of certain cancers and there are dozens of other agents in clinical trials, she said.
Cancer cells rely on increased protein synthesis
Genes express messenger RNA, which is in turn processed through a cell's ribosomes to produce a specific protein, a step called translation.
"Cancer cells need a lot of protein synthesis to grow and survive," Meric-Bernstam said. She and colleagues systematically analyzed several major translation-regulating proteins in tumors from 190 patients with stage 1 to stage 3 hormone receptor-positive breast cancer. Median follow-up was 96 months.
They found four aberrations that were predictors of overall survival. They remained significant even after multivariable analysis accounting for other factors such as age and node-positive status that also affect survival. They are:
Increased phosphorylation of ribosomal protein S6 (pS6) and of translation initiation factor 4E-binding protein 1 (p4E-BP1).
Increased expression of eukaryotic elongation factor 2 kinase (eEF2K).
Decreased expression of programmed cell death protein 4 (pdcd4).
Their findings, if validated by additional studies, could lead to markers that help select patients who may have a high risk of relapse if treated with traditional endocrine therapy alone and identify those who might benefit from an additional targeted therapy, Meric-Bernstam noted.
Results from a major phase III clinical trial presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium showed that the mTOR inhibitor everolimus increased progression-free survival when combined with the hormonal therapy exemestane to treat resistant hormone receptor-positive breast cancer.
"As we understand how to select patients better we'll be able to more efficiently use these targeted therapies to improve outcomes for breast cancer patients," Meric-Bernstam said.
###
Other M.D. Anderson collaborators on the study are Huiqin Chen, Gabriel Hortobagyi M.D., and Ana Gonzalez-Angulo, M.D., of the Department of Breast Medical Oncology; Argun Akcakanat, M.D., Ph.D., of the Department of Surgical Oncology; Kim-Anh Do, Ph.D., of the Department of Biostatistics; and Gordon Mills, M.D., Ph.D., of the Department of Systems Biology. Ana Lluch, M.D., Ph.D., Hospital Clinico Universitario de Valencia, Valencia, Spain and Bryan Hennessy, M.D., Beaumont Hospital, Dublin, Ireland, also collaborated on the project.
This research was funded by an AACR-Stand Up To Cancer Dream Team Award, Susan G. Komen for the Cure, the Society of Surgical Oncology Clinical Investigator Award and the National Cancer Institute Cancer Center Support Grant to MD Anderson.
About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. For eight of the past 10 years, including 2011, MD Anderson has ranked No. 1 in cancer care in the "Best Hospitals" survey published annually in U.S. News & World Report.
END
Rutgers scientists think they have found a way to prevent and possibly reverse the most debilitating symptoms of a rare, progressive childhood degenerative disease that leaves children with slurred speech, unable to walk, and in a wheelchair before they reach adolescence.
In today's online edition of Nature Medicine, Karl Herrup, chair of the Department of Cell Biology and Neuroscience in the School of Arts and Sciences provides new information on why this genetic disease attacks the cerebellum – a part of the brain that controls movement coordination, equilibrium, and ...
SALT LAKE CITY -- A study led by a University of Utah astrophysicist found a new explanation for the growth of supermassive black holes in the center of most galaxies: they repeatedly capture and swallow single stars from pairs of stars that wander too close.
Using new calculations and previous observations of our own Milky Way and other galaxies, "we found black holes grow enormously as a result of sucking in captured binary star partners," says physics and astronomy Professor Ben Bromley, lead author of the study, which is set for online publication April 2 in Astrophysical ...
Tracy Hayward, Founder of The Perfect Puree of Napa Valley, announced today the kick-off of an Enter-to-Win sweepstakes. Entitled "Whisk, Shake & Stir The Perfect Puree," the sweepstakes will offer one lucky winner a week in Napa, California, during the renowned Culinary Institute of America's Worlds of Flavor Conference on November 1 - 3, 2012.
The online sweepstakes is open to all and there is no purchase necessary to enter. Entrants simply sign up at the "Whisk, Shake, and Stir" contest page on the Perfect Puree website between April 2 and ...
ROCHESTER, Minn. -- Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. According to a study by
Mayo Clinic researchers published in the April issue of Mayo Clinic Proceedings, the incidence of melanoma has escalated, and young women are the hardest hit.
"We anticipated we'd find rising rates, as other studies are suggesting, but we found an even higher incidence than the National Cancer Institute had reported using the Surveillance, Epidemiology and End Result ...
OAKLAND, Calif., (April 2, 2012) — Vaccines for measles were not associated with an increased risk of febrile seizures among 4-6 year olds during the six weeks after vaccination, according to a study by the Kaiser Permanente Vaccine Study Center that appears in the current issue of Pediatrics.
Funded by the U.S. Centers for Disease Control, the study of 86,750 children follows an earlier study published in Pediatrics that showed one particular combination of measles-containing vaccine — the measles, mumps, rubella and chickenpox containing vaccination (or MMRV) — ...
Madeira Optical knows the challenges of 21st century medical practice. When they decided to moved to a new location at 7800 Laurel Ave. Madeira, OH 45243 on March 1st of 2012, Madeira Optical was faced with relocating a complex server and terminal practice management software package. Moving medical equipment and adding a state-of-the art exam lane were also on the agenda. So, Madeira Optical decided to convert from a locally maintained server to the iManaged Solutions virtual hosted environment. When Madeira Optical moved to 7800 Laurel Ave., all they have to do is connect ...
New research confirms that childhood onset temporal lobe epilepsy has a significant impact on brain aging. Study findings published in Epilepsia, a peer-reviewed journal of the International League Against Epilepsy (ILAE), show age-accelerated ventricular expansion outside the normal range in this patient population.
According to the Centers for Disease Control and Prevention (CDC), epilepsy affects nearly 2 million Americans. Temporal lobe epilepsy is the most common form of partial epilepsy, with 60% of all patients having this form of the disease. Previous evidence ...
PHILADELPHIA -- Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.
"This is a major breakthrough in immunotherapy research because we were able to use purified cancer stem cells to generate a vaccine, which strengthened the potency of antibodies and T cells that selectively targeted cancer stem cells," said Qiao Li, Ph.D., a research assistant professor in the department of surgery ...
Why do some persons succumb to post-traumatic stress disorder (PTSD) while others who suffered the same ordeal do not? A new UCLA study may shed light on the answer.
UCLA scientists have linked two genes involved in serotonin production to a higher risk of developing PTSD. Published in the April 3 online edition of the Journal of Affective Disorders, the findings suggest that susceptibility to PTSD is inherited, pointing to new ways of screening for and treating the disorder.
"People can develop post-traumatic stress disorder after surviving a life-threatening ordeal ...
CHICAGO -- Because cases of Triple-Negative Breast Cancer (TNBC) are so genetically different, whole-genome sequencing is needed to detect the subtle molecular differences that might point to specific treatments for individual patients.
Dr. John Carpten, Ph.D., head of the Integrated Cancer Genomics Division at the Translational Genomics Research Institute (TGen), will deliver that message along with other preliminary findings about whole-genome sequencing of TNBC at the American Association for Cancer Research (AACR) Annual Meeting 2012, March 31-April 4, in Chicago.
"Every ...
